Spire Healthcare Group plc
LSE:SPI.L
Sector
Industries
Location
Market Cap
USD 1.18 B
Share Price
USD 2.89
Avg Daily Volume
943,912
Change (1 day)
-2.92%
Change (1 year)
-12.68%
Change (YTD)
2.23%
Spire Healthcare Group plc Selling, General, and Administrative Expenses (SG&A) for the year ending December 31, 2024: USD 0.00
Spire Healthcare Group plc Selling, General, and Administrative Expenses (SG&A) is USD 0.00 for the year ending December 31, 2024, a -100.00% change year over year. Selling, general, and administrative (SG&A) expenses are the expenses related to the sales and marketing efforts, as well as general and administrative functions of a company.
-
Spire Healthcare Group plc Selling, General, and Administrative Expenses (SG&A) for the year ending December 31, 2023 was USD 501.43 M, a 23.37% change year over year.
-
Spire Healthcare Group plc Selling, General, and Administrative Expenses (SG&A) for the year ending December 31, 2022 was USD 406.44 M, a -4.01% change year over year.
-
Spire Healthcare Group plc Selling, General, and Administrative Expenses (SG&A) for the year ending December 31, 2021 was USD 423.43 M, a 5.90% change year over year.
-
Spire Healthcare Group plc Selling, General, and Administrative Expenses (SG&A) for the year ending December 31, 2020 was USD 399.85 M, a 15.05% change year over year.
StockViz
Competitors
Edwards Lifesciences Corporation
USD 78.16
EW
-0.19
-0.24%
Cardinal Health, Inc.
USD 157.66
CAH
+0.25
0.16%
Fresenius SE & Co. KGaA
USD 50.88
FRE.DE
-0.04
-0.08%
Terumo Corporation
USD 18.74
4543.T
+0.22
1.21%
STERIS plc
USD 241.62
STE
-1.23
-0.51%
Aier Eye Hospital Group Co., Ltd.
USD 1.80
300015.SZ
-0.01
-0.56%
Fresenius Medical Care AG & Co. KGaA
USD 48.16
FME.DE
+0.25
0.53%
Baxter International Inc.
USD 23.46
BAX
-0.23
-0.97%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 7.88
603392.SS
+0.01
0.07%
Fortis Healthcare Limited
USD 10.54
FORTIS.NS
+0.04
0.40%
Shenzhen New Industries Biomedical Engineering Co., Ltd.
USD 8.06
300832.SZ
+0.15
1.96%
Getinge AB (publ)
USD 20.54
GETI-B.ST
-0.03
-0.12%
SOL S.p.A.
USD 56.05
SOL.MI
-0.12
-0.22%
Merit Medical Systems, Inc.
USD 84.04
MMSI
-1.54
-1.80%
Bumrungrad Hospital Public Company Limited
USD 5.87
BH.BK
+0.01
0.17%
Key Data
| Date | Selling, General, and Administrative Expenses (SG&A) | Research and Development (R&D) Expenses | Revenue | Revenue |
|---|
Competitors
Edwards Lifesciences Corporation
USD 78.16
EW
-0.19
-0.24%
Cardinal Health, Inc.
USD 157.66
CAH
+0.25
0.16%
Fresenius SE & Co. KGaA
USD 50.88
FRE.DE
-0.04
-0.08%
Terumo Corporation
USD 18.74
4543.T
+0.22
1.21%
STERIS plc
USD 241.62
STE
-1.23
-0.51%
Aier Eye Hospital Group Co., Ltd.
USD 1.80
300015.SZ
-0.01
-0.56%
Fresenius Medical Care AG & Co. KGaA
USD 48.16
FME.DE
+0.25
0.53%
Baxter International Inc.
USD 23.46
BAX
-0.23
-0.97%
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
USD 7.88
603392.SS
+0.01
0.07%
Fortis Healthcare Limited
USD 10.54
FORTIS.NS
+0.04
0.40%
Shenzhen New Industries Biomedical Engineering Co., Ltd.
USD 8.06
300832.SZ
+0.15
1.96%
Getinge AB (publ)
USD 20.54
GETI-B.ST
-0.03
-0.12%
SOL S.p.A.
USD 56.05
SOL.MI
-0.12
-0.22%
Merit Medical Systems, Inc.
USD 84.04
MMSI
-1.54
-1.80%
Bumrungrad Hospital Public Company Limited
USD 5.87
BH.BK
+0.01
0.17%